Content about Papillomavirus

January 16, 2014

The Food and Drug Administration on Thursday issued a warning that some cryogenic wart removers — which remove warts from the skin by freezing them off — have caught fire during use at home, harming consumers or setting fire to items around the house.

SILVER SPRING, Md. — The Food and Drug Administration on Thursday issued a warning that some cryogenic wart removers — which remove warts from the skin by freezing them off — have caught fire during use at home, harming consumers or setting fire to items around the house.

Since 2009, FDA has received 14 such reports about over-the-counter wart remover products. Ten patients have described singed hair, blisters, burns or skin redness, the agency stated.

November 15, 2013

An experimental human papillomavirus vaccine made by Merck could offer a boost to the vaccine market, but the company will have to use effective marketing efforts to ensure uptake, according to a new study.

LONDON — An experimental human papillomavirus vaccine made by Merck could offer a boost to the vaccine market, but the company will have to use effective marketing efforts to ensure uptake, according to a new study.

The London-based research and consulting firm GlobalData said Merck's V503 vaccine, currently in phase-3 clinical trials, had strong potential because it protects against five HPV types not covered by current vaccines and demonstrates 97% efficacy against precancerous lesions caused by the additional virus types it contains.

September 11, 2013

A vaccine to slow the progression of HIV and a monoclonal antibody that protects against influenza are among the nearly 300 vaccines under development by drug makers in the United States, according to a new report by a drug industry trade group.

WASHINGTON — A vaccine to slow the progression of HIV and a monoclonal antibody that protects against influenza are among the nearly 300 vaccines under development by drug makers in the United States, according to a new report by a drug industry trade group.

September 10, 2013

Media Enterprises scored big with the introduction of the As Seen on TV product Tag Away into the mass market.

TREVOSE. Pa. — Media Enterprises scored big with the introduction of the As Seen on TV product Tag Away into the mass market. Within its first year on shelf, the homeopathic solution that promises to remove skin tags naturally has generated more than $18.3 million. That makes Tag Away one of the more significant contributors to the 18.4% annualized growth within wart removers, which generated $125.2 million in overall sales for the 52 weeks ended July 14 across total U.S. multi-outlets, according to IRI data.

 
July 26, 2013

While rates of human papillomavirus infection among girls ages 14 years to 19 years have dropped by half since the Centers for Disease Control and Prevention started recommending routine vaccination against it seven years ago, rates of vaccination have not increased, the agency said.

ATLANTA — While rates of human papillomavirus infection among girls ages 14 years to 19 years have dropped by half since the Centers for Disease Control and Prevention started recommending routine vaccination against it seven years ago, rates of vaccination have not increased, the agency said.

According to the CDC's Morbidity and Mortality Weekly Report, HPV vaccination coverage for girls did not increase over last year. The survey included vaccination records of about 19,000 teenagers.

July 19, 2013

Boys whose mothers receive flu shots or Pap screenings are more likely to receive the human pappilomavirus vaccine, according to a new study.

PASADENA, Calif. — Boys whose mothers receive flu shots or Pap screenings are more likely to receive the human pappilomavirus vaccine, according to a new study.

The study, conducted by Kaiser Permanente and published in the American Journal of Public Health, was based on electronic health records of more than 250,000 boys aged 9 to 17 enrolled in the Kaiser Permanente Southern California health plan.

June 20, 2013

Under a new law, pharmacists in Indiana will be able to provide an expanded range of immunizations that includes human papillomavirus.

NEW YORK — Under a new law, pharmacists in Indiana will be able to provide an expanded range of immunizations that includes human papillomavirus.

June 13, 2013

Only 15.5% of college students know that condoms don't fully protect a person from contacting the human papillomavirus, and this lack of knowledge can lead students to a false sense of security in their sexual practices, according to a new study in Radiologic Technology, a journal published by the American Society of Radiologic Technologists.

ALBUQUERQUE, N.M. — Only 15.5% of college students know that condoms don't fully protect a person from contacting the human papillomavirus, and this lack of knowledge can lead students to a false sense of security in their sexual practices, according to a new study in Radiologic Technology, a journal published by the American Society of Radiologic Technologists.

March 28, 2012

As pharmacies become increasingly involved in flu shots, retail-based clinics are expanding into other areas of vaccination — such as vaccines to help protect against human papillomavirus, meningitis and pneumonia — to further meet the healthcare needs of patients.

As pharmacies become increasingly involved in flu shots, retail-based clinics are expanding into other areas of vaccination — such as vaccines to help protect against human papillomavirus, meningitis and pneumonia — to further meet the healthcare needs of patients.

January 25, 2012

A human papillomavirus vaccine created by drug maker Merck does not cause autoimmune conditions after young women are inoculated, according to a new Kaiser Permanente study.

PASADENA, Calif. — A human papillomavirus vaccine created by drug maker Merck does not cause autoimmune conditions after young women are inoculated, according to a new Kaiser Permanente study.

October 25, 2011

An advisory committee of the Centers for Disease Control and Prevention is recommending that all boys ages 11 and 12 years old get vaccinated against human papillomavirus, the CDC said Tuesday.

ATLANTA — An advisory committee of the Centers for Disease Control and Prevention is recommending that all boys ages 11 and 12 years old get vaccinated against human papillomavirus, the CDC said Tuesday.

The agency said the Advisory Committee on Immunization Practices voted for recommending routine vaccination of boys with three doses of HPV4 to protect against the virus. The vaccination is able to prevent such HPV-related conditions as cancer and prevent the spread of the virus to sexual partners. The recommendation is still subject to the CDC's approval, the agency said.

September 20, 2011

Health experts have expressed fear that Republican presidential candidate Michele Bachmann's comments about the human papillomavirus vaccine could set back progress in vaccinations, according to published reports.

NEW YORK — Health experts have expressed fear that Republican presidential candidate Michele Bachmann's comments about the human papillomavirus vaccine could set back progress in vaccinations, according to published reports.

The New York Times quoted experts as saying that vaccination rates often drop when public figures raise alarms about vaccines, including one who said it could set back efforts to vaccinate against human papillomavirus — a sexually transmitted infection that causes genital warts and several cancers in men and women — by three years.

September 15, 2011

GlaxoSmithKline is making a donation that it said would give more than 10,000 girls and women access to human papillomavirus vaccination.

LONDON — GlaxoSmithKline is making a donation that it said would give more than 10,000 girls and women access to human papillomavirus vaccination.

GSK announced that it would donate $1 million worth of Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant) to the Pink Ribbon Red Ribbon Partnership over the next five years, as well as $50,000 to support the program operations. The partnership is an initiative led by Susan G. Komen for the Cure, UNAIDS, the President's Emergency Relief Plan for AIDS Relief and the George W. Bush Institute.

September 14, 2011

Attacks on a human papillomavirus vaccine made amid an increasingly caustic Republican presidential primary battle have drawn a response from the manufacturer.

NEW YORK — Attacks on a human papillomavirus vaccine made amid an increasingly caustic Republican presidential primary battle have drawn a response from the manufacturer.

September 6, 2011

Hemispherx Biopharma and Armada Health Care have entered a sales and marketing agreement for a drug designed to treat genital warts.

PHILADELPHIA — Hemispherx Biopharma and Armada Health Care have entered a sales and marketing agreement for a drug designed to treat genital warts.

The two companies announced Tuesday an agreement under which Hemispherx will manufacture and supply Alferon N injection (interferon alfa-n3 [human leukocyte derived]) to physicians and patients through Armada's national specialty pharmacy network. Specialty distributor BioRidge Pharma will warehouse, ship and distribute the drug, the companies said.

August 26, 2011

Increases in vaccination rates for the human papillomavirus are trailing increases in rates for two other vaccines recommended for teens and preteens, according to data from the Centers for Disease Control and Prevention released Thursday.

ATLANTA — Increases in vaccination rates for the human papillomavirus are trailing increases in rates for two other vaccines recommended for teens and preteens, according to data from the Centers for Disease Control and Prevention released Thursday.

Coverage rates for the other two vaccines — Tdap, which protects against tetanus, diphtheria and pertussis; and MenACWY, which protects against meningococcal meningitis — are continuing to increase, but vaccination rates for HPV vaccine remain low, the study found.

April 25, 2011

CVS Caremark's MinuteClinic division has expanded its suite of services to now include vitamin B12 injections and the human papillomavirus vaccination Gardasil.

WOONSOCKET, R.I. — CVS Caremark's MinuteClinic division has expanded its suite of services to now include vitamin B12 injections and the human papillomavirus vaccination Gardasil.

March 28, 2011

The Food and Drug Administration has approved a topical treatment for genital warts made by Graceway Pharmaceuticals, the drug maker said Monday.

BRISTOL, Tenn. — The Food and Drug Administration has approved a topical treatment for genital warts made by Graceway Pharmaceuticals, the drug maker said Monday.

The FDA approved Zyclara (imiquimod) cream in the 3.75% strength for patients ages 12 years and older. According to clinical trial data, the cream effectively cleared genital warts, and of patients who achieved complete clearance, only a small percentage had a recurrence 12 weeks after treatment.

February 3, 2011

Merck’s vaccine for human papillomavirus is 89% effective in preventing genital warts in teenage boys and young men, according to a new study.

WHITEHOUSE STATION, N.J. — Merck’s vaccine for human papillomavirus is 89% effective in preventing genital warts in teenage boys and young men, according to a new study.

The phase-3 study of Gardasil (human papillomavirus quadrivalent [types 6, 11, 16 and 18] vaccine, recombinant) in boys and men ages 16 to 26 years was published in the Feb. 3 issue of the New England Journal of Medicine. Human papillomavirus is the cause of genital and anal warts, and infection can increase the risk of developing cancer later in life.

December 23, 2010

Merck on Wednesday announced that the Food and Drug Administration has approved Gardasil [human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant] for the prevention of anal cancer in males and females 9 to 26 years of age.

WHITEHOUSE STATION, N.J. — Merck on Wednesday announced that the Food and Drug Administration has approved Gardasil [human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant] for the prevention of anal cancer in males and females 9 to 26 years of age.

According to the company, Gardasil is the first HPV vaccine on the market available for use in both men and women, and the only one indicated  to help prevent cervical, vaginal, vulvar and anal cancers and pre-cancers, as well as genital warts, caused by certain types of HPV.

November 16, 2010

A Food and Drug Administration advisory committee has recommended expanded approval of a vaccine for...

WHITEHOUSE STATION, N.J. — A Food and Drug Administration advisory committee has recommended expanded approval of a vaccine for genital warts.

Merck announced Wednesday that the FDA Vaccines and Related Biological Products Advisory Committee recommended approval of Gardasil (human papillomavirus quadrivalent [types 6, 11, 16 and 18] vaccine, recombinant) for males and females ages 9 to 26 years to prevent anal cancer and anal intraepithelial neoplasia, both diseases that result from infection by the human papillomavirus.

September 28, 2010

GlaxoSmithKline has tapped soccer star Mia Hamm for its public health campaign to emphasize the...

PHILADELPHIA GlaxoSmithKline has tapped soccer star Mia Hamm for its public health campaign to emphasize the need for adults to make vaccinations part of their overall health-and-wellness goals.

GSK's Give Your Health a Shot campaign underscores the need for adults to receive vaccinations as a preventative measure to protect their health. The campaign announcement followed the pertussis (whooping cough) outbreak that has affected California.

September 8, 2010

The Food and Drug Administration has approved a generic drug for treating skin diseases made...

ALLEGAN, Mich. The Food and Drug Administration has approved Perrigo's generic drug for treating skin diseases, the drug maker said Wednesday.

 

The FDA approved Perrigo’s imiquimod cream in the 5% strength. The drug is a generic version of Graceway Pharmaceuticals’ Aldara.

 

 

The drug is used to treat actinic keratoses on the face and scalp, superficial basal cell carcinoma and external genital and perianal warts in patients ages 12 years and older.

 

February 17, 2010

A vaccine made by Merck for preventing human papillomavirus works for preventing anal warts and...